24 January 2024
Events
Case Studies on Opill and Naloxone: Key Takeaways from the Latest Switch Approvals and What They Mean for Future Industry Opportunities
Foley partner Kyle Faget, co-chair of the firm’s Health Care Practice Group, is speaking at the Advanced Legal, Regulatory and Compliance Forum on OTC Drugs in a panel titled “Case Studies on Opill and Naloxone: Key Takeaways from the Latest Switch Approvals and What They Mean for Future Industry Opportunities.”
